Clinical trials
Recruiting Mesothelioma, Malignant trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
46 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2019 | 2 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 12 |
| 2024 | 12 |
| 2025 | 5 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 46 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 3 |
| A2 Biotherapeutics Inc. | 2 |
| Intergroupe Francophone de Cancerologie Thoracique | 2 |
| National Cancer Institute (NCI) | 2 |
| University College, London | 2 |
| University Hospital, Antwerp | 2 |
| University of Chicago | 2 |
| 7 Hills Pharma, LLC | 1 |
| Aalborg University Hospital | 1 |
| Abramson Cancer Center at Penn Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 46 |
| Mesothelioma | 11 |
| Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Colorectal Neoplasms | 7 |
| Neoplasm Metastasis | 7 |
| Ovarian Neoplasms | 6 |
| Lung Neoplasms | 5 |
| Pancreatic Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
Trials
Showing 26 to 46 of 46. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.